Molecular approaches to management of epithelial ovarian cancer

被引：29

作者：

Bast, RC

Yu, Y

Xu, FJ

Le, XF

Mills, GB

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Div Med, Dept Expt Therapeut, Houston, TX 77030 USA

[2] Univ Texas, MD Anderson Canc Ctr, Div Med, Dept Mol Therapeut, Houston, TX 77030 USA

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2000年 / 10卷

关键词：

D O I：

10.1046/j.1525-1438.2000.99502.x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：2 / 7

页数：6

共 51 条

[1] Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase [J].

Adam, L ;

Vadlamudi, R ;

Kondapaka, SB ;

Chernoff, J ;

Mendelsohn, J ;

Kumar, R .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (43) :28238-28246

[2] Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast [J].

Baselga, J ;

Tripathy, D ;

Mendelsohn, J ;

Baughman, S ;

Benz, CC ;

Dantis, L ;

Sklarin, NT ;

Seidman, AD ;

Hudis, CA ;

Moore, J ;

Rosen, PP ;

Twaddell, T ;

Henderson, IC ;

Norton, L .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :737-744

[3] ELEVATION OF SERUM CA 125 PRIOR TO DIAGNOSIS OF AN EPITHELIAL OVARIAN-CARCINOMA [J].

BAST, RC ;

SIEGAL, FP ;

RUNOWICZ, C ;

KLUG, TL ;

ZURAWSKI, VR ;

SCHONHOLZ, D ;

COHEN, CJ ;

KNAPP, RC .

GYNECOLOGIC ONCOLOGY, 1985, 22 (01) :115-120

[4]

BAST RC, IN PRESS MOL BASIS C

[5] OVEREXPRESSION OF P53 IS NOT A FEATURE OF BENIGN AND EARLY-STAGE BORDERLINE EPITHELIAL OVARIAN-TUMORS [J].

BERCHUCK, A ;

KOHLER, MF ;

HOPKINS, MP ;

HUMPHREY, PA ;

ROBBOY, SJ ;

RODRIGUEZ, GC ;

SOPER, JT ;

CLARKEPEARSON, DL ;

BAST, RC .

GYNECOLOGIC ONCOLOGY, 1994, 52 (02) :232-236

[6]

BERCHUCK A, 1990, CANCER RES, V50, P4087

[7]

ENOMOTO T, 1990, CANCER RES, V50, P6139

[8] SOMATIC ACTIVATION OF RASK-GENE IN A HUMAN OVARIAN-CARCINOMA [J].

FEIG, LA ;

BAST, RC ;

KNAPP, RC ;

COOPER, GM .

SCIENCE, 1984, 223 (4637) :698-700

[9]

GERSHENSON DM, IN PRESS CLIN CANC R

[10]

Hagopian GS, 1999, CLIN CANCER RES, V5, P655

← 1 2 3 4 5 6 →